Technical Analysis for BCDA - BioCardia, Inc.

Grade Last Price % Change Price Change
F 3.26 -2.98% -0.10
BCDA closed down 2.98 percent on Tuesday, July 27, 2021, on 1.16 times normal volume.
Earnings due: Aug 11
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical BCDA trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
20 DMA Resistance Bearish -2.98%
Fell Below 200 DMA Bearish -2.98%
180 Bearish Setup Bearish Swing Setup -2.98%
Outside Day Range Expansion -2.98%
200 DMA Support Bullish -12.13%
Wide Bands Range Expansion -12.13%
200 DMA Support Bullish -10.68%
MACD Bullish Signal Line Cross Bullish -10.68%
Wide Bands Range Expansion -10.68%
Older End-of-Day Signals for BCDA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapeutics for cardiovascular diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia. The company is also developing CardiALLO Cell Therapy System, an investigational culture expanded bone marrow derived from mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system; and Morph vascular access product line, which provides catheter products. BioCardia, Inc. is based in San Carlos, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Bone Stem Cells Catheter Cardiovascular Disease Heart Failure Cell Therapy Regenerative Medicine Vascular Diseases Cardiovascular Diseases Bone Marrow Vascular Access Aging Associated Diseases Ischemia Heart Diseases Treatment Of Heart Failure

Is BCDA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.6
52 Week Low 1.91
Average Volume 85,689
200-Day Moving Average 3.65
50-Day Moving Average 4.04
20-Day Moving Average 3.62
10-Day Moving Average 3.49
Average True Range 0.26
ADX 28.01
+DI 12.71
-DI 26.39
Chandelier Exit (Long, 3 ATRs) 3.78
Chandelier Exit (Short, 3 ATRs) 3.99
Upper Bollinger Bands 4.06
Lower Bollinger Band 3.18
Percent B (%b) 0.09
BandWidth 24.37
MACD Line -0.19
MACD Signal Line -0.18
MACD Histogram -0.0075
Fundamentals Value
Market Cap 40.52 Million
Num Shares 12.4 Million
EPS -3.20
Price-to-Earnings (P/E) Ratio -1.02
Price-to-Sales 66.80
Price-to-Book 7.46
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.67
Resistance 3 (R3) 3.70 3.59 3.60
Resistance 2 (R2) 3.59 3.49 3.58 3.57
Resistance 1 (R1) 3.43 3.43 3.38 3.40 3.55
Pivot Point 3.32 3.32 3.30 3.31 3.32
Support 1 (S1) 3.16 3.22 3.11 3.13 2.97
Support 2 (S2) 3.05 3.16 3.04 2.95
Support 3 (S3) 2.89 3.05 2.92
Support 4 (S4) 2.86